Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer

NCT00038402 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Herceptin
DRUG: Taxol
DRUG: Fluorouracil
DRUG: Cytoxan
DRUG: Epirubicin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]